Centre Hospitalier De Troyes
- Address
- 101 Avenue Anatole France, 10000 Troyes, France
Centre Hospitalier De Troyes - Specialized Clinical Research Center
Centre Hospitalier De Troyes is a comprehensive medical research institution engaged in diverse clinical investigations spanning hematologic malignancies, neonatal emergency care, and critical care medicine. The center demonstrates particular expertise in conducting multicenter trials that address complex therapeutic challenges across multiple patient populations, from newborns to elderly patients.
- Hematologic disorders including multiple myeloma, myelodysplastic syndromes, chronic myelogenous leukemia, and polycythemia vera
- Neonatal resuscitation and respiratory support techniques for preterm and full-term newborns
- Acute infectious diseases and systemic autoimmune conditions in adult populations
The research portfolio reflects a strong commitment to both emergency interventions and long-term disease management strategies. Notable work includes innovative approaches to umbilical vein catheterization in delivery room resuscitation, sedation protocols for less invasive surfactant administration in preterm infants, and novel combination therapies for hematologic cancers. The center also participates in studies evaluating extended immunosuppressive therapy for ANCA-associated vasculitis and optimizing treatment timing for myelodysplastic syndrome patients, demonstrating comprehensive capabilities in managing rare and complex medical conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 3 of 7 therapeutic areas and 15 of 32 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 7 by active trials.
lock +6 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 978 other sites in France
Therapeutic Area Benchmark — France
Select a therapeutic area to compare against other sites in France.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: France
Market Share
Country: France
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centre Hospitalier De Troyes
lock Showing 1 of 13 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparison of mFOLFIRINOX Versus Platinum-Etoposide in First-Line Chemotherapy for Metastatic Grade 3 Gastroenteropancreatic Neuroendocrine Carcinoma | Centre Hospitalier Universitaire De Dijon | Phase II | Recruiting | Oct 2024 | — |
IMP list
lock Showing 1 of 32 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexamethasone | 3 | Unknown | 2021-06-11 | 2024-12-12 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.